Label: PEPTIC RELIEF tablet

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated January 11, 2022

If you are a consumer or patient please visit this version.

  • Active ingredient (in each tablet)

    Bismuth Subsalicytate 262mg

  • Purpose

    Upset stomach reliever / anti-diarrheal

  • KEEP OUT OF REACH OF CHILDREN

  • Uses

    relieves:

    • diarrhea
    • hearbrun
    • indigesttion
    • nausea
    • upset stomach associated with these symptoms
  • Warnings

    Reye's syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome, a rare but serious illness.

    Allergy alert: Contains salicylate. Do not take if you are

    • allergic to salicylates (including aspirin)
    • taking other salicylate products

    Do not use if you have

    • if you have bloody or black stool
    • an ulcer
    • a bleeding problem

    Ask a doctor before use if you have

    • fever
    • mucus in the stool

    Ask a doctor or pharmacist before use if you are taking any drug for

    • anticoagulation (thinning the blood)
    • diabetes
    • gout
    • arthritis

    When using this product a temporary, but harmless, darkening of the stool and/or tongue may occur.

    Stop use and ask a doctor if
    • symptoms get worse
    • ringing in the ears or loss of hearing occurs
    • diarrhea lasts more than 2 days

    If pregnant or breast-feeding, 

    ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center immediately.

  • Directions

    • chew or dissolve in mouth
    • adults and children 12 years and over: 2 tablets every 1/2 to 1 hour as needed
    • do not take more than 8 doses (16 tablets) in 24 hours
    • use until diarrhea stops but not more than 2 days
    • children under 12 years: ask a doctor
    • drink plenty of clear fluids to help prevent dehydration caused by diarrhea
  • Other information

    • each tablet contains: salicylate 102mg
    • sodium less than 1 mg 
    • very low sodium
    • avoid excessive heat (over 104ºF or 40ºC) 
  • Inactive ingredients

    calcium carbonate, D&C red #27 aluminum lake, flavor, magnesium stearate, mannitol, pregelatinized starch, saccharin sodium

  • Questions or comments?

    1-800-645-2158

  • PDP

    COMPARE TO THE ACTIVE INGREDINET IN PEPTO-BISMOL®*

    Rugby®

    NDC 0536-1021-07

    Peptic Relief

    Bismuth Subsalicylate 262 mg

    FOR UPSET STOMACH, INDIGESTION, SIMPLE DIARRHEA AND NAUSEA

    30 CHEWABLE TABLETS

    image description

  • INGREDIENTS AND APPEARANCE
    PEPTIC RELIEF 
    peptic relief tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0536-1021
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BISMUTH SUBSALICYLATE (UNII: 62TEY51RR1) (SALICYLIC ACID - UNII:O414PZ4LPZ, BISMUTH CATION - UNII:ZS9CD1I8YE) BISMUTH SUBSALICYLATE262 mg
    Inactive Ingredients
    Ingredient NameStrength
    D&C RED NO. 27 (UNII: 2LRS185U6K)  
    CALCIUM CARBONATE (UNII: H0G9379FGK)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MANNITOL (UNII: 3OWL53L36A)  
    STARCH, CORN (UNII: O8232NY3SJ)  
    SACCHARIN SODIUM (UNII: SB8ZUX40TY)  
    Product Characteristics
    ColorPINKScoreno score
    ShapeROUNDSize18mm
    FlavorImprint Code GDC;122
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0536-1021-0730 in 1 BOTTLE; Type 0: Not a Combination Product02/20/2014
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC MONOGRAPH FINALpart33502/20/2014
    Labeler - Rugby Laboratories (079246066)
    Establishment
    NameAddressID/FEIBusiness Operations
    Guardian Drug Company119210276manufacture(0536-1021)